Siehler_2007_Expert.Opin.Drug.Discov_2_1591

Reference

Title : G12\/13-dependent signaling of G-protein-coupled receptors: disease context and impact on drug discovery - Siehler_2007_Expert.Opin.Drug.Discov_2_1591
Author(s) : Siehler S
Ref : Expert Opin Drug Discov , 2 :1591 , 2007
Abstract :

G-protein-coupled receptors (GPCRs) transmit extracellular signals across the plasma membrane via intracellular activation of heterotrimeric G proteins. The signal transduction pathways of Gs, Gi and Gq protein families are widely studied, whereas signaling properties of G12 proteins are only emerging. Many GPCRs were found to couple to G12/13 proteins in addition to coupling to one or more other types of G proteins. G12/13 proteins couple GPCRs to activation of the small monomeric GTPase RhoA. Activation of RhoA modulates various downstream effector systems relevant to diseases such as hypertension, artherosclerosis, asthma and cancer. GPCR screening assays exist for Gs-, Gi- and Gq-linked pathways, whereas a drug-screening assay for the G12-Rho pathway was developed only recently. The review gives an overview of the present understanding of the G12/13-related biology of GPCRs.

PubMedSearch : Siehler_2007_Expert.Opin.Drug.Discov_2_1591
PubMedID: 23488903

Related information

Citations formats

Siehler S (2007)
G12\/13-dependent signaling of G-protein-coupled receptors: disease context and impact on drug discovery
Expert Opin Drug Discov 2 :1591

Siehler S (2007)
Expert Opin Drug Discov 2 :1591